[1]
Khan, A.R.S. and Bai, R. 2026. Preemptive EBV-specific T-cell therapy: an emerging prophylactic approach to PTLD reduction and survival benefit in SOT recipients. Journal of the Pakistan Medical Association. 76, 02 (Jan. 2026), 280–280. DOI:https://doi.org/10.47391/JPMA.31018.